Bioequivalence and Bioavailability Forum 08:05 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by EKY - Thailand, 2019-01-04 03:08  - Posting: # 19727
Views: 173

According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.

In the bioanalysis for quantification of methylphenidate in plasma, there are some hemolysis samples.

Has anyone experienced that hemolysis samples (plasma) affect the bioanalysis or the reported plasma concentrations?

Can the respective plasma concentrations from hemolysis samples be fallacious?

Best Regards,

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,016 posts in 4,056 threads, 1,297 registered users;
online 13 (0 registered, 13 guests [including 8 identified bots]).

The only people who see the whole picture are the ones
who step out of the frame.    Salman Rushdie

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed